LifeStance (LFST) Soars 30% on Q3 Earnings Blowout

We recently published 10 Stocks on Fire Amid Market Chaos. LifeStance Health Group, Inc. (NASDAQ:LFST) is one of the best-performing stocks on Thursday.

LifeStance recovered by 29.94 percent on Thursday to close at $6.25 apiece as investors welcomed its impressive earnings performance in the third quarter of the year, solidifying expectations for a strong 2025.

In an updated report, LifeStance Health Group, Inc. (NASDAQ:LFST) said it swung to a net income of 1.077 million from a $5.9 million net loss in the same period last year. Total revenues increased by 16 percent to $363.8 million from $312.7 million year-on-year.

The figures supported the company’s nine-month recovery, with net loss shrinking by 96 percent to only $2 million from $50.3 million in the same period last year. Total revenues stood at $1.04 billion, higher by 12.6 percent than the $925 million year-on-year.

“This was a record-breaking quarter for LifeStance,” said LifeStance Health Group, Inc. (NASDAQ:LFST) CEO Dave Bourdon. “This performance reflects improved operating leverage in G&A and positions us to raise our full-year Adjusted EBITDA guidance while continuing to expand margins into 2026. The team’s exceptional results this quarter provide strong momentum as we enter the fourth quarter and look ahead to the coming year.”

Looking ahead, LifeStance Health Group, Inc. (NASDAQ:LFST) maintained its revenue growth outlook of $1.41 billion to $1.43 billion for full-year 2025 and raised its adjusted EBITDA expectations to a range of $146 million to $152 million, from $140 million to $150 million previously.

For the fourth quarter alone, revenues are targeted at $368 million to $388 million, while adjusted EBITDA is projected at $37 million to $43 million.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.